The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation

Author： Leist Thomas P.   Vermersch Patrick  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.11, 2007-11, pp. : 2667-2676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cladribine Treatment of a Patient with Hairy Cell Leukemia and Concomitant Multiple Sclerosis

By  

Acta Haematologica, Vol. 102, Iss. 2, 1999-10 ,pp. : 99-100

Karger

Access to resources Recommend Favorite

Cladribine tablets and multiple sclerosis: NICE technology appraisal

By  

PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 22, Iss. 1, 2018-01 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cladribine for highly active relapsing multiple sclerosis

By  

PRESCRIBER, Vol. 29, Iss. 2, 2018-02 ,pp. : 37-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (Review)

By            

International Journal of Molecular Medicine, Vol. 28, Iss. 4, 2011-01 ,pp. : 467-479

Spandidos Publications

Access to resources Recommend Favorite

Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands

By Karampampa Korinna  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 939-950

Informa Healthcare

Access to resources Recommend Favorite